Osmetech Plc (OMH) Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
4/26/2010 6:41:23 AM
More...
|
FDA Clears Osmetech Plc (OMH)'s Cystic Fibrosis Genotyping Test
7/9/2009 6:42:57 AM
More...
|
Osmetech Plc (OMH) Board Sets its Sights on the Future
7/1/2009 9:04:20 AM
More...
|
Osmetech Plc (OMH)'s Exclusive Warfarin CYP4F2 Biomarker Included in Leading Warfarindosing.org Algorithm
6/8/2009 12:12:43 PM
More...
|
Osmetech Plc (OMH)'s eSensor XT-8 platform wins Medical Design Excellence Award
5/14/2009 9:32:10 AM
More...
|
Osmetech Plc (OMH) Chosen as Principal Supplier for a Major Clinical Trial
5/13/2009 10:01:31 AM
More...
|
Osmetech Plc (OMH) and Fisher HealthCare Sign U.S. Distribution Agreement
4/2/2009 9:42:59 AM
More...
|
Osmetech Plc (OMH) Withdraws $44 Million IPO
12/5/2008 6:59:30 AM
More...
|
Osmetech Plc (OMH) Clinical Trials Commence for Extended Warfarin Sensitivity Test
11/10/2008 12:10:48 PM
More...
|
Osmetech Plc (OMH) Announces CYP450 2C9 Test Launch
11/4/2008 10:13:05 AM
More...
|
|